A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

12.4K views

⸱

DOI:

10.3791/57904

⸱

August 11th, 2018

In This Article

Summary

Here we present a protocol to produce gram-negative Escherichia coli (E. coli) spheroplasts and gram-positive Bacillus megaterium (B. megaterium) protoplasts to clearly visualize and rapidly characterize peptide-bacteria interactions. This provides a systematic method to define membrane localizing and translocating peptides.

Abstract

The use of confocal microscopy as a method to assess peptide localization patterns within bacteria is commonly inhibited by the resolution limits of conventional light microscopes. As the resolution for a given microscope cannot be easily enhanced, we present protocols to transform the small rod-shaped gram-negative Escherichia coli (E. coli) and gram-positive Bacillus megaterium (B. megaterium) into larger, easily imaged spherical forms called spheroplasts or protoplasts. This transformation allows observers to rapidly and clearly determine whether peptides lodge themselves into the bacterial membrane (i.e., membrane localizing) or cross the membrane to enter the cell (i.e., translocating). With this approach, we also present a systematic method to characterize peptides as membrane localizing or translocating. While this method can be used for a variety of membrane-active peptides and bacterial strains, we demonstrate the utility of this protocol by observing the interaction of Buforin II P11A (BF2 P11A), an antimicrobial peptide (AMP), with E. coli spheroplasts and B. megaterium protoplasts.

Introduction

Antimicrobial peptides (AMPs) have gained attention due to their potential use as alternatives to conventional antibiotics1,2,3,4,5. AMPs kill bacteria by either translocating across the cell membrane and interacting with intracellular components such as nucleic acids or by permeabilizing the membrane causing leakage of cell contents6. In addition to their use as antibiotics, translocating AMPs may be adapted for drug delivery applications because they ca....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Solution Preparation

NOTE: Prepare solutions described in steps 1.1–1.9 and 1.8–1.11 in order to produce E. coli spheroplasts and B. megaterium protoplasts, respectively.

  1. Prepare 1 M Tris-Cl, pH 7.8 by dissolving 10.34 g Tris HCl and 4.17 g of Tris OH in 50 mL of dH2O in a 125 mL flask. Sterilize by filtering through a 25 mm syringe filter with a 0.2 µm membrane and store in a conical tube at room temperature.
  2. Prepare solution A (20 mM MgCl2, 0.7 M sucrose, 10 mM Tris-Cl, pH 7.8) by dissolving 0.10 g MgCl2 (95.2 g/mol) and 11.98 g sucrose (342.3 g/mol) in 25 mL dH

Access restricted. Please log in or start a trial to view this content.

Results

By enlarging bacteria and making them spherical, we can easily distinguish whether peptides localize to the bacterial membrane or readily translocate across the bacterial membrane. The resolution limits of conventional light microscopes make it challenging to distinguish whether peptide signals arise from the membrane or intracellular space in normal bacteria because signals localized to the membrane will appear to overlap with the intracellular space (Figure 3A

Access restricted. Please log in or start a trial to view this content.

Discussion

The protocols presented here make it feasible for researchers to more rapidly obtain larger sample sizes of bacterial images because the enlarged, spherical bacteria are much easier to locate, orient, and image. This enhanced ability to collect data is valuable in several respects. First, it enables a more systematic quantitative analysis of peptide localization patterns. While qualitative trends can be demonstrated from smaller sets of images, only a large sample set of high-quality images reveal more nuanced trends in .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest are declared.

Acknowledgements

Research was supported by National Institute of Allergy and Infectious Diseases (NIH-NIAID) award R15AI079685.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Trizma hydrocloride (Tris HCl)SigmaT3253
Trizma base (Tris OH)SigmaT1503
Magnesium chlorideSigmaM8266
SucroseSigmaS7903
LysozymeSigmaL6876
Deoxyribonuclease ISigmaD4527
Ethylenediaminetetraacetic acidSigma106361Used Sigma 106361 in original protocol development; 106361 discontinued with ED2SS as replacement
Cephalexin hydrateSigmaC4895
AmpicillinFisher ScientificBP1760
BBL Trypticase soy brothFisher ScientificB11768
BF2 P11A FITCNeoScientificCustom ordered
di-8-ANEPPSBiotium61012
DMSOSigma34869Used Sigma D8779 in original protocol development; D8779 discontinued with 34869 as replacement
Maleic acidSigmaM0375
Acrodisc 25 mm Syringe Filter w/ 0.2 μm HT Tuffryn MembranePall Corporation4192
Laser scanning confocal microscopeLeica MicrosystemsTCS SP5 IIFor image acquisition
Leica Application Suite, Advanced FluorescenceLeica MicrosystemsFor image processing

References

  1. Baltzer, S. A., Brown, M. H. Antimicrobial peptides: promising alternatives to conventional antibiotics. Journal of Molecular Microbiology Biotechnology. 20 (4), 228-235 (2011).
  2. Hancock, R. E., Sahl, H. G. Antimicr....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Protoplast FormationConfocal MicroscopyPeptide Membrane InteractionE. coli SpheroplastsB. megaterium ProtoplastsFluorescent Peptide TrackingCell Membrane AnalysisPeptide Translocation Assay